Novo Nordisk Foundation
Investigator Initiated Clinical Trials
Call opens 9 June 2026; closes 18 August 2026 at 2:00pm Copenhagen time. Results announced end December 2026.
Last verified:
Details
| Funder | Novo Nordisk Foundation |
| Budget | DKK 6–22 million per grant |
| Deadline | 18 August 2026 |
| Duration | 3-5 years |
| Application | Single stage |
| Frequency | Annual |
| Next round | 2027-06 |
| Eligible countries | DK |
Eligibility & scope
Funds larger non-commercial investigator-initiated clinical trials in Denmark (monocentric or multicenter). For international multicenter trials, the coordinating investigator and trial must be anchored at a Danish hospital. Trials with industrial/commercial purpose are excluded. Applicants must be mid-career or established research leaders. Trials must conform to GCP guidelines.
More from Novo Nordisk Foundation
Interdisciplinary Synergy Programme 2026
Deadline: 20 May 2026Up to DKK 19.4 million per grantNovo Nordisk Foundation Interdisciplinary Synergy Programme 2026
Deadline: 20 May 2026Up to DKK 19.4M (~€2.6M)Steno Collaborative Grants
Deadline: 2 Jun 2026DKK 1M–DKK 10M per grant (total pool up to DKK 30M)Non-Diabetic Endocrinology Collaborative Grants 2026
Deadline: 3 Jun 2026DKK 5M–10M per grant (total pool up to DKK 53M)Project grants in Endocrinology and Metabolism – Nordic Region
Deadline: 4 Jun 2026Up to DKK 4.5 million per grant
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free